000 01435 a2200397 4500
005 20250513114401.0
264 0 _c19970603
008 199706s 0 0 eng d
022 _a0378-1097
024 7 _a10.1111/j.1574-6968.1997.tb10303.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLamb, D C
245 0 0 _aDifferential inhibition of Candida albicans CYP51 with azole antifungal stereoisomers.
_h[electronic resource]
260 _bFEMS microbiology letters
_cApr 1997
300 _a25-30 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntifungal Agents
_xchemistry
650 0 4 _aBinding Sites
_xphysiology
650 0 4 _aCandida albicans
_xdrug effects
650 0 4 _aChlorobenzenes
_xchemistry
650 0 4 _aCytochrome P-450 Enzyme Inhibitors
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aFungal Proteins
_xantagonists & inhibitors
650 0 4 _aOxidoreductases
_xantagonists & inhibitors
650 0 4 _aStereoisomerism
650 0 4 _aSterol 14-Demethylase
650 0 4 _aTriazoles
_xchemistry
700 1 _aKelly, D E
700 1 _aBaldwin, B C
700 1 _aGozzo, F
700 1 _aBoscott, P
700 1 _aRichards, W G
700 1 _aKelly, S L
773 0 _tFEMS microbiology letters
_gvol. 149
_gno. 1
_gp. 25-30
856 4 0 _uhttps://doi.org/10.1111/j.1574-6968.1997.tb10303.x
_zAvailable from publisher's website
999 _c9086390
_d9086390